【27】A systematic review and meta-analysis of all randomized controlled trials comparing PSA screening with usual care in men without a diagnosis of prostate cancer concluded that PSA screening for prostate cancer leads to ...
自此,美国PSA筛查率及前列腺癌发病率显著下降。 USPSTF的建议是基于ERSPC (European Randomized Study of Screening for Prostate Cancer) (注册号: ISRCTN49127736) 及 PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial) (N...
Joy Melnikow. (2018). Prostate-Specific Antigen–Based Screening for Prostate Cancer Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2018;319(18):1914-1931. doi:10.1001/jama.2018.3712.
Prof Dmitry Pshezhetskiy, from UEA's Norwich Medical School, said: "Prostate cancer is the most common cancer in men and kills one man every 45 minutes in the UK. "There is currently no single test for prostate cancer, but PSA blood tests are among the most used, alongside physical exam...
Duffy MJ. Biomarkers for prostate cancer: prostate-specific antigen and beyond. Clin Chem Lab Med. 2020 Feb 25;58(3):326-339. doi: 10.1515/cclm-2019-0693. PMID: 31714881. Numan A, Singh S, Zhan Y, Li L, Khalid M, Rilla K, Ranjan S, Cinti S. Advanced nanoengineered-customized poin...
[6] Moyer VA; US Preventive Services Task Force. (2012). Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012 Jul 17;157(2):120-34. doi: 10.7326/0003-4819-157-2-201207170-00459. ...
Reports on the findings of a study stating that prostate-specific antigen (PSA) blood levels of 4 ng/ml detected 79 percent of prostate cancers. Three detection methods supported by the American College of Surgeons; How the study was performed; Cost of a PSA test; Support for transrectal ...
[17]Niu X, Li J, Das SK, Xiong Y, Yang C, Peng T. Developing a nomogram based on multiparametric magnetic resonance imaging for forecasting high-grade prostate cancer to reduce unnecessary biopsies within the prostate-specific antigen gray zone. BMC Med Imaging. 2017; 17(1): 11. ...
[7] Tim M. Govers, et al.Cost-effectivenessof SelectMDx for prostate cancer in four European countries: a comparativemodeling study. Prostate Cancer and Prostatic Diseases(2018). doi: 10.1038/s41391-018-0076-3. [8] Veeru Kasivisvanathan, et al.MRI-Targeted or Standard Biopsy for Prostate-...
2.Vettenranta A, et al. Outcomes of Screening for Prostate Cancer Among Men Who Use Statins. JAMA Oncol. Published online November 24, 2021.https://jamanetwork.com/journals/jamaoncology/article-abstract/2786538 3.https://mp.weixin.qq.com/s/knnMnRtQqePkoTCIl5LYgw ...